ascopubs.org

Survival of de novo and secondary acute promyelocytic leukemia: A propensity matched analysis of the Surveillance, Epidemiology and End Results database.

Impact of nilotinib treatment on subclinical cardiovascular biomakers. Four-year minimum follow-up of ongoing patients (pts) with chronic-phase chronic myeloid leukemia (CP-CML) in a phase 1 trial of ...
TCTMD

Sapien 3 in Intermediate Risk: Death or Stroke Similar to SAVR at 5 Years

A new propensity-matched analysis looking at 5-year clinical outcomes in intermediate-risk patients with severe symptomatic aortic stenosis shows similar rates of all-cause mortality and stroke among ...
MedPage Today

One CAR T-Cell Therapy for Multiple Myeloma Tops Another in Propensity Matched Study

SAN DIEGO -- In a propensity-matched comparison of two CAR T-cell therapies, ciltacabtagene autoleucel (cilta-cel, Carvykti) demonstrated better efficacy than idecabtagene vicleucel (ide-cel, Abecma) ...
JSTOR Daily

Effects of graded return-to-work: a propensity-score-matched analysis

This is a preview. Log in through your library . Abstract Objectives Graded work exposure is deemed to have a therapeutic effect. In Germany, graded return-to-work (GRTW) is therefore frequently used ...
ascopubs.org

De-escalation of five years adjuvant endocrine therapy duration in patients with ER-low positive (immunohistochemical 1% to 10%) early-stage breast cancer: A propensity-matched ...

Clinical validation of EndoPredict in premenopausal women with estrogen receptor-positive (ER+), human epidermal growth factor receptor 2-negative (HER2-) primary breast cancer. This is an ASCO ...
MedPage Today on MSN

Liver disease medication linked to lower cancer risks

Treatment with ursodeoxycholic acid (UDCA) in adults with primary biliary cholangitis (PBC) was associated with significantly lower risks of certain cancers, a retrospective propensity-score matched ...